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Multiparous sows (n 17) were included in a controlled cross-over-study in order to investigate the influence of a natural source of conjugated
linoleic acid (CLA) (alpine butter) on the milk fatty acid composition of lactating sows (as an animal model for lactating women) and on the
growth performance of their progeny. The usual fat source of a standard lactation diet was replaced by either CLA-rich alpine butter or margarine
(control diet). Compared with the margarine diet, feeding the alpine butter-supplemented diet increased (P,0·001) the CLA concentration in the
milk fat (742·3 (SD 272·0) v. 107·7 (SD 34·7) mg/100 g fat). Eleven of fourteen CLA isomers were higher (P#0·004) in milk fat after feeding the
alpine butter-supplemented diet but the transfer was not proportional. The milk fat concentration of the sow milk and the level of SFA, MUFA and
PUFA were not (P.0·05) affected. Growth performance of the progeny was similar for both dietary treatments. In summary, the findings show
that adding alpine butter to the diet does not provoke a milk fat depression and does not alter the composition of total SFA, MUFA and PUFA in
sow milk but increases its CLA concentration.
Conjugated linoleic acid: Milk: Sows: Lipids: Alpine butter
Conjugated linoleic acid (CLA) constitutes a mixture of pos-
itional and geometrical isomers of linoleic acid (cis-9,cis-12-
18 : 2) and is naturally found in ruminant milk and meat.
CLA has been demonstrated to have various beneficial
health effects in animal models such as anti-adipogenic, anti-
carcinogenic, anti-atherogenic, antidiabetic, and immune-
enhancing effects(1). However, for humans the data are not
yet conclusive. The various CLA isomers have been shown
to have different physiological effects(2). The two major iso-
mers with known physiological activities are cis-9,trans-11-
18 : 2 and trans-10,cis-12-18 : 2. In rats enhanced pup weight
gain was determined when dams were fed a diet supplemented
with CLA during the lactation period(3). Similarly, in sows a
diet supplemented with synthetic CLA during gestation and
lactation markedly altered the fatty acid composition of the
colostrum and mature milk and higher body weight at weaning
was found in piglets weaned from sows fed the CLA-sup-
plemented diet(4,5).
Diets rich in high-fat dairy products increased cis-9,trans-11-
18 : 2 and total lipid concentrations of human milk(6,7). By
contrast, supplementing the maternal diet with commercially
synthesised CLA, which contains in addition to cis-9,trans-11-
18 : 2 also a substantial amount of trans-10,cis-12-18 : 2,
resulted in a marked increase of the concentration of both iso-
mers whereas the milk fat concentration was lowered compared
with the control diet(8). When maternal diets were supplemented
with cheese containing a high CLA concentration (about 360 mg
CLA/100 g cheese) levels of cis-9,trans-11-18 : 2 were
increased but the fat concentration of the breast milk was not
altered compared with the diet supplemented with cheese con-
taining low CLA levels(9).
Results from animal studies suggest that cis-9,trans-11-18 : 2
may be active in enhancing body-weight gain of the offspring
whereas trans-10,cis-12-18 : 2 is responsible for depression of
milk fat(2,9). This indicates that naturally CLA-rich dairy pro-
ducts (high cis-9,trans-11-18 : 2 and low trans-10,cis-12-18 : 2
concentrations) may be a better option for supplementing the
maternal diet than synthetic CLA supplements.
Total CLA and isomer concentrations in dairy milk depend on
age, breed and the diet composition(10,11). Pasture feeding was
shown to result in higher total CLA concentrations than concen-
trate feeding(12) and significantly higher cis-9,trans-11-, trans-
11,cis-13-, trans-8,cis-10-18 : 2 and total CLA concentrations
were found in milk of highland cows than in their lowland
counterparts(13,14). Alpine butter is a food naturally rich in
CLA that can easily be employed in the human diet. A recent
randomised, controlled, cross-over study investigated CLA
and fatty acid concentrations in human milk from mothers con-
suming CLA-rich alpine butter or margarine in addition to their
normal diet(15). Although total CLA concentration was signifi-
cantly increased in the milk of mothers offered the alpine
butter, large variations were observed in regard to individual
CLA isomers and among mothers. Furthermore, only five of
fourteen CLA isomers were significantly increased and some
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mothers had decreasing values of certain CLA isomers when
given the CLA-rich alpine butter. Whether these variations
were due to the lack of compliance as suggested or are due to
naturally occurring between-subject differences is difficult to
determine. Sows, being single-stomached animals with strong
dietary and digestive similarities to humans(16), may be perfect
as a model to verify the findings of the aforementioned human
trial. Thus, the objective of the present study was to investigate
the transfer of various CLA isomers from a natural dietary CLA
source (alpine butter) into the milk of lactating sows and the
influence on milk fatty acid composition and milk fat content.
Our hypothesis was that a supplementation of the sow diet
with CLA-rich alpine butter will increase the concentrations
of the CLA isomers in the sow milk compared with a control
diet without CLA. Furthermore, the findings were to be com-
pared with the results of the previous human study.
Experimental methods
Experimental diets, animals, and study design
One basal lactation diet was formulated according to the Swiss
Feeding Recommendation for lactating sows(17). The usually
included animal fat source (blend of tallow and pig fat) was
entirely replaced by either CLA-rich alpine butter (BU; exper-
imental diet) or margarine (MA; control diet) (Table 1).
The ingredient calculation was done for production units of
500 kg, which resulted in 61 g alpine butter or margarine per
kg feed. The alpine butter, which contained 859 g fat/kg, ori-
ginated from the Alp Mutten (2100 m altitude; Graubu¨nden,
Switzerland), was produced in summer 2004 and stored until
use at 2208C. The fat content of the margarine (Goldina,
Florin AG, Switzerland) was 800 g/kg. The fat content and
fatty acid composition of both diets are shown in Table 2.
The study was designed as a cross-over experiment and car-
ried out with seventeen multiparous sows (Swiss Large White)
at the ALP Swine facility in Posieux (Switzerland) between
January and May 2005. At the beginning of the adaptation
period, which started 5 to 10 d before farrowing and lasted
until day 5 after farrowing, the sows were blocked by body
weight (seven blocks with two sows and one block with
three sows per body-weight block) and randomly assigned
within each block to two treatment groups. Before farrowing,
all sows were offered 2 kg of the MA diet and within the 5 d
after farrowing the daily allowance of the MA diet was gradu-
ally increased from 2 to 5·2 kg per sow. From day 5 until day
15 and from day 16 until day 25, nine sows were offered
5·2 kg of BU and MA diet (treatment group A: BU–MA).
Eight sows in treatment group B (MA–BU) were offered
Table 1. Composition of lactation diets with alpine butter (BU) and mar-
garine (MA) (g/kg)*
Treatment
BU MA
Wheat 282 282
Maize 226 226
Dry sugarbeet pulp 100 100
Soyabean meal 257 257
Rapeseed meal 50 50
NaCl 4 4
Dicalcium phosphate 5 5
Calcium carbonate 7 7
Vitamin–mineral premix† 4 4
Pellan 4 4
Alpine butter 61 0
Margarine 0 61
* Lactation diet was formulated to contain 13·5 MJ digestible energy and 12 g crude
protein per MJ digestible energy.
† Supplied the following nutrients (per kg diet): 1·2 mg all-trans retinol, 0·006 mg
cholecalciferol, 9·9 mg vitamin E, 2·8 mg riboflavin, 1·3 mg vitamin B6, 0·015 mg
vitamin B12, 0·2 mg vitamin K3, 102 mg pantothenic acid, 10 mg niacin,
0·48 mg folic acid, 84 mg Fe as iron sulfate, 0·56 mg I as Ca(IO)3, 0·2 mg Se as
Na2Se, 9·2 mg Cu as CuSO4, 81 mg Zn as ZnO2, 2·5 mg Mn as MnO2, 196 g
choline and 0·99 mg biotin.
Table 2. Total lipid content (per 100 g dry matter) and fatty acid con-
centrations (per 100 g fat) of alpine butter (BU) and margarine (MA)
lactation diets
Treatment
BU MA
Total lipids (g per 100 g DM) 8·86 8·55
Fatty acid concentrations (per 100 g fat)
14 : 0 (g) 4·60 3·17
15 : 0 (g) 0·69 0·02
16 : 0 (g) 16·16 18·88
17 : 0 (g) 0·46 0·05
18 : 0 (g) 7·32 3·71
18 : 1 t 9 (g) 0·17 0·03
18 : 1 c 9 (g) 19·43 20·88
18 : 1 t 10/11 (g) 2·53 0·10
18 : 2 c 9,c 12 (g) 15·78 21·46
CLA isomers
18 : 2 t 12,t 14 (mg) 12·53 0·99
18 : 2 t 11,t 13 (mg) 22·75 0·39
18 : 2 t 10,t 12 (mg) 2·04 4·16
18 : 2 t 9,t 11 (mg) 41·87 6·76
18 : 2 t 8,t 10 (mg) 4·24 4·48
18 : 2 t 7,t 9 (mg) 5·01 1·96
18 : 2 t 6,t 8 (mg) 2·17 0·92
18 : 2 ct /tc 12,14 (mg) 0·05 0·66
18 : 2 t 11,c 13 (mg) 75·65 0·57
18 : 2 c 11,t 13 (mg) 2·85 0·91
18 : 2 t 10,c 12 (mg) 1·71 4·18
18 : 2 c 9,t 11 (mg) 1003·95 11·65
18 : 2 t 8,c 10 (mg) 13·00 2·95
18 : 2 t 7,c 9 (mg) 22·60 0·91P
CLA (mg) 1210·42 41·49
18 : 3 c 9,c 12,c 15 (g) 2·16 1·85
20 : 3n-6 (g) 0·02 0·05
20 : 4n-6 (g) 0·07 0·02
SFA (g)* 36·33 35·92
MUFA (g)† 26·83 24·49
PUFA (g)‡ 21·80 24·73P
18 : 1 t (g)§ 3·43 0·21P
18 : 2 (g) 19·35 22·67
t FA without CLA (g)k 4·54 0·52
t FA with CLA (g){ 5·65 0·55P
n-3 (g) 4·17 2·89P
n-6 (g) 16·95 22·12
n-6:n-3 4·06 7·65
t , trans; c , cis; CLA, conjugated linoleic acid; FA, fatty acids.
* C4 to C10, C12, C12 iso, C12 aiso, C13 iso, C14, C14 iso, C14 aiso, C15, C15
iso, C16, C16 iso, C16 aiso, C17, C17 iso, C17 aiso, C18, C19, C20 and C22.
† C10 : 1, C14 : 1 ct , C16 : 1 ct , C17 : 1 ct , C18 : 1 t4 to C18 : 1 c14,t16, C20 : 1 t ,
C20 : 1 c5 to C20 : 1 c11.
‡ C18 : 2 tt non-methylene interrupted diene to C18 : 2 c9,c15, C18 : 3 c6,c9,c12,
C18 : 3 c9,c12,c15 to C20 : 2 cc , C20 : 3 to C22 : 6.
§ C18 : 1 t4 to C18 : 1 t13–14 þ c6–8.
kC14 : 1 t , C16 : 1 t , C17 : 1 t , C20 : 1 t , C18 : 1 t þ C18 : 2 t (without CLA t ).
{C14 : 1 t , C16 : 1 t , C17 : 1 t , C20 : 1 t , C18 : 1 t þ C18 : 2 t þ CLA t .
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the MA and BU diet from day 5 to day 15 and from day 16 to
day 25, respectively. Based on literature data, it was expected
that alterations in the milk lipid composition due to the dietary
treatment would occur quickly(6,8,15). Therefore, a washout
period between the two dietary treatments was omitted in
favour of a waiting period before collecting the first milk
samples (5 d). In the adaptation and experimental phase the
sows were individually fed twice per d and had free access
to water. In order to have the same daily feed intake, litter
size was adjusted to eight piglets on the day of farrowing.
Each sow ingested daily 5·4 g CLA with the BU diet compared
with an intake of only 0·2 g CLA with the MA diet. All pro-
cedures involving animals were approved by the Swiss Federal
Committee for Animal Care and Use.
Measurements and sampling
The body weight of the piglets was recorded at birth and at
days 5, 15 and 25 of age between 07.00 and 09.00 hours.
The pigs did not have access to feeds other than the milk.
Milk samples (50 ml per sow and milking) were collected by
milking several udders on days 5, 10, 15, 20 and 25 from
all sows, on day 7 from sows in treatment group A, and on
day 17 from sows in treatment group B at 09.00 hours. The
piglets were separated from the sows 2 h before milking. In
order to facilitate milking, 3 ml oxytocin (Oxytocin-20;
Graeub, Bern, Switzerland) was injected intramuscularly
before milking. The milk samples were frozen immediately
and stored at 2208C until analysis.
Sample analysis
Milk fat was obtained gravimetrically using the Ro¨se Gottlieb
method(18). The milk fat was dissolved in hexane, and the
acylglycerols were transesterified to the corresponding fatty
acid methyl esters using a solution of potassium hydroxide
in methanol (2 mol/l) according to ISO standard 15 885.
Fatty acid composition was determined using a gas chromato-
graph (Agilent 6890) equipped with an on-column injector and
flame ionisation detector(19). Nearly seventy fatty acids were
separated on a capillary column (100 m £ 0·25 mm £ 0·20mm,
CP-Sil 88) and quantified in absolute values (g fatty acids/
100 g fat) using nonanoic acid as internal standard. CLA iso-
mers were analysed by silver-ion (Agþ) HPLC according to
Rickert et al. (20), modified by Kraft et al. (21). The analysis
was performed on an Agilent LC series 1100 equipped
with a photodiode array detector (234 nm) using three
ChromSpher Lipids columns in series. The solvent consisted
of UV-grade hexane with 0·1 % acetonitrile and 0·5 % ethyl
ether (flow rate 1 ml/min) prepared fresh daily. Injection
volumes were 10ml, representing ,250mg lipid. The identi-
fication of CLA isomers was based on co-injection with
commercial reference material and synthesised CLA. The
results were expressed as absolute values in mg per 100 g
fat. Fourteen different CLA isomers were separated by this
HPLC method.
Statistical analysis
Statistical analysis was performed using Systatw for Windows
version 11 (Richmond, CA, USA) and Microsoft Excel 2000.
The fatty acid concentrations are expressed as means and
pooled standard errors of a difference between means. The
two measurements for milk fatty acid concentrations within
the same dietary phase (study days 10 þ 15 and 20 þ 25,
respectively) were compared using paired t tests. All compari-
sons were not statistically significant (P.0·05). Subsequently,
the two measurements within a dietary phase were averaged
for further statistical analysis. The unpaired two-tailed t test
for cross-over design was used to assess differences in milk
fatty acid concentrations regarding dietary treatment, and diet-
ary order. Differences between means were considered statisti-
cally significant at the P,0·05 level. ‘Dietary treatment’
refers to the impact of the two fat sources (BU v. MA) of
the pooled data of both groups; ‘dietary order’ reflects the
effect of the order of the treatment.
Results
The fat content of both diets was similar with 8·86 v. 8·55 g/
100 g DM and both diets showed a similar SFA concentration.
Higher levels of vaccenic acid (trans-11-18 : 1; VA) in the
alpine butter led to a slightly higher MUFA concentration in
the BU diet. The PUFA concentration was somewhat higher
in the MA diet but not as much as would have been expected
in regard to the more pronounced linoleic acid (cis-9,cis-12-
18 : 2) content of the MA diet. The reason for this lies in the
higher concentration of n-3 fatty acids in the BU compared
with the MA diet, which is reflected in the n-6:n-3 ratios of
4·06 and 7·65 for the BU and MA diets, respectively. Total
CLA concentration as well as ten of the fourteen analysed
CLA isomers was higher in the BU diet. Exceptions were
trans-10,trans-12-, trans-8,trans-10-, trans-10,cis-12-, and
cis-12,trans-14/trans-12,cis-14-18 : 2.
Compared with the MA diet, feeding the BU diet did not
alter the fat content of the sow milk (Table 3). The fatty
acid profile of the sow milk fat generally reflected the fatty
acid profile of the diet. The concentration of linoleic acid in
the milk fat increased (P¼0·008) during the MA feeding.
However, the concentration of myristic (14 : 0), palmitic
(16 : 0), stearic (18 : 0), oleic (cis-9-18 : 1), and a-linolenic
(cis-9,cis-12,cis-15-18 : 3) fatty acids as well as the total
amount of SFA, MUFA, and PUFA were not influenced by
the diets (P.0·05). An increased trans-18 : 1 concentration
in the milk fat during the BU feeding (P,0·001) was noted.
As expected, feeding the BU diet resulted in a significantly
higher (P,0·001) total CLA concentration in the milk fat
(Table 3). The transfer of CLA from diet into milk occurred
rapidly. Within 2 d after the change from the MA to the BU
diet CLA concentrations in milk were elevated (data not
shown). Fourteen individual CLA isomers were separated by
HPLC analysis. All CLA isomers determined in the feed
were detected in the sow milk fat. Eleven of the fourteen
measured CLA isomers increased (P#0·004) during the BU
feeding (Table 3). Exceptions were trans-10,trans-12-, trans-
10,cis-12- and trans-8,trans-10-18 : 2, which is not surprising
since the concentration of these isomers was equal or higher
in the MA compared with the BU diet. Interestingly, the
concentration of cis-12,trans-14/trans-12,cis-14-18 : 2 in milk
was significantly (P,0·001) increased during the BU
diet although the concentration was higher in MA than in
BU. The most abundant isomers found in the sow milk after
A. Schmid et al.56
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BU feeding were cis-9,trans-11-18 : 2, followed by trans-7,
cis-9-18 : 2, trans-8,cis-10-, trans-9,trans-11-, and trans-11,
cis-13-18 : 2. There was no (P.0·05) dietary order effect for
the concentration of individual CLA isomers.
The growth performance of the progeny was not influenced
by the dietary treatments (Fig. 1). During the BU diet of the
sows the body weight of the litter increased 2·48 (SD 0·78)
kg; during the MA diet 2·52 (SD 0·81) kg. The difference
was not statistically significant (P¼0·82).
Discussion
The present study demonstrates that a 10 d supplementation
with alpine butter, a naturally CLA-rich product, affects
the CLA isomer content of sow milk without influencing
significantly the total fat content and the overall composition
of SFA, MUFA and PUFA.
No influence of trans-10,cis-12-18 : 2 on total milk fat as
previously shown by Masters et al. (8) was noticed, probably
because of the very low concentration of this isomer in both
diets.
In general, the fatty acid profile of the sow milk reflected
that of the diet. However, the small differences in the concen-
tration of total MUFA and PUFA in the two diets did not lead
to significant differences in the sow milk fat. The higher con-
centration of linoleic acid in MA may be the reason for the
increased linoleic acid concentration in the milk fat during
MA feeding but the effect was not powerful enough to have
a statistically significant impact on the total PUFA concen-
tration. The difference in the linoleic acid concentration was
more important (dietary order effect; P¼0·04) in treatment
Table 3. Total lipid content (per 100 g milk) and fatty acid concentrations of sow milk (per 100 g milk fat) during alpine
butter (BU) and margarine (MA) treatment
(Mean values and pooled standard errors of difference)
Group A (n 9) Group B (n 8) P
BU MA MA BU SED Dietary treatment Dietary order
Total lipid (g/100 g milk) 6·94 7·21 8·19 7·93 4·60 0·33 0·79
Fatty acid concentrations (per 100 g milk fat)
14 : 0 (g) 3·78 3·45 3·78 3·85 0·15 0·02 0·10
15 : 0 (g) 0·29 0·14 0·15 0·30 0·03 ,0·01 0·91
16 : 0 (g) 27·10 27·92 27·55 26·61 1·05 0·11 0·91
17 : 0 (g) 0·43 0·27 0·29 0·38 0·03 ,0·01 0·09
18 : 0 (g) 4·42 4·20 3·82 3·92 0·23 0·18 0·62
18 : 1 t9 (g) 0·17 0·10 0·12 0·19 0·01 ,0·01 0·44
18 : 1 c9 (g) 24·51 25·51 24·92 25·14 1·21 0·53 0·33
18 : 1 t10/11 (g) 0·60 0·33 0·22 0·60 0·09 ,0·01 0·25
18 : 2 c9,c12 (g) 10·62 13·45 12·73 12·27 1·08 ,0·01 0·05
CLA isomers
18 : 2 t12,t14 (mg) 1·78 0·44 0·35 2·00 0·45 ,0·01 0·51
18 : 2 t11,t13 (mg) 3·37 1·30 0·73 3·19 0·65 ,0·01 0·55
18 : 2 t10,t12 (mg) 1·22 1·84 1·21 1·21 0·31 0·07 0·07
18 : 2 t9,t11 (mg) 12·91 6·98 5·44 14·61 1·96 ,0·01 0·12
18 : 2 t8,t10 (mg) 1·26 2·38 2·03 1·59 0·36 ,0·01 0·07
18 : 2 t7,t9 (mg) 3·13 1·80 2·12 3·50 0·65 ,0·01 0·94
18 : 2 t6,t8 (mg) 0·34 0·18 0·24 0·41 0·08 ,0·01 0·99
18 : 2 ct/tc 12,14 (mg) 0·42 0·25 0·26 0·49 0·12 ,0·01 0·63
18 : 2 t11,c13 (mg) 12·91 0·84 0·72 14·56 2·59 ,0·01 0·50
18 : 2 c11,t13 (mg) 2·30 0·98 0·81 2·54 0·28 ,0·01 0·16
18 : 2 t10,c12 (mg) 5·27 7·42 3·73 4·45 1·65 0·40 0·10
18 : 2 c9,t11 (mg) 610·40 88·25 65·92 725·68 122·19 ,0·01 0·28
18 : 2 t8,c10 (mg) 13·31 3·35 2·47 15·11 2·56 ,0·01 0·31
18 : 2 t7,c9 (mg) 14·65 6·07 5·58 17·76 2·80 ,0·01 0·22P
CLA (mg) 683·27 122·07 91·59 808·65 132·84 ,0·01 0·26
18 : 3 c9,c12,c15 (g) 0·89 0·89 0·82 1·02 0·12 0·11 0·12
20 : 3n-6 (g) 0·07 0·08 0·08 0·09 0·01 0·65 0·15
20 : 4n-6 (g) 0·36 0·34 0·42 0·39 0·05 0·84 0·40
SFA (g)* 38·08 38·23 37·97 37·19 1·17 0·44 0·60
MUFA (g)† 35·95 36·21 36·55 37·05 1·01 0·82 0·46
PUFA (g)‡ 14·17 16·14 15·08 16·16 1·37 0·52 0·04P
18 : 1 t (g)§ 0·97 0·55 0·42 0·99 0·11 ,0·01 0·21P
18 : 2 (g) 12·20 13·98 13·43 14·01 1·23 0·34 0·07
t FA with CLA (g)k 2·19 0·93 0·75 2·34 0·27 ,0·01 0·24
n-6:n-3 7·00 9·36 9·33 7·10 0·63 ,0·01 0·85
t, trans; c, cis; CLA, conjugated linoleic acid; FA, fatty acids.
* C4 to C10, C12, C12 iso, C12 aiso, C13 iso, C14, C14 iso, C14 aiso, C15, C15 iso, C16, C16 iso, C16 aiso, C17, C17 iso, C17 aiso, C18,
C19, C20 and C22.
† C10 : 1, C14 : 1 ct, C16 : 1 ct, C17 : 1 ct, C18 : 1 t4 to C18 : 1 c14,t16, C20 : 1 t, C20 : 1 c5 to C20 : 1 c11.
‡ C18 : 2 tt non-methylene interrupted diene to C18 : 2 c9,c15, C18 : 3 c6,c9,c12, C18 : 3 c9,c12,c15 to C20 : 2 cc , C20 : 3 to C22 : 6.
§ C18 : 1 t4 to C18 : 1 t13–14 þ c6–8.
kC14 : 1 t, C16 : 1 t, C17 : 1 t, C20 : 1 t, C18 : 1 t þ C18 : 2 t þ CLA t.
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group A (BU–MA) than in treatment group B (MA–BU) and
might be caused by the longer foregoing phase with MA feed-
ing of the latter.
There was no significant dietary order effect for the concen-
tration of individual CLA isomers. Therefore, it can be
assumed that the waiting period of 5 and 10 d, respectively,
before milk was sampled was long enough to eliminate any
carry-over effect.
Dietary VA is converted to cis-9,trans-11-18 : 2 in human
and animal tissues(22 – 25). In humans the conversion rate is
estimated to be about 19 %(23). Because alpine butter naturally
contains VA, it has to be assumed that the cis-9,trans-11-18 : 2
found in the sow milk partially derived from VA. To estimate
the transfer of VA, we calculated a discrimination factor (i.e.
the relationship of the percentage trans-18 : 1 isomer of the
total MUFA content in the milk fat as compared with that
of the diet) as proposed by Pettersen & Opstvedt(26). The cal-
culated discrimination factor for trans-10/trans-11-18 : 1 was
0·17, indicating that only a small proportion of VA was actu-
ally transferred into the milk fat. Calculating the discrimi-
nation factor for cis-9,trans-11-18 : 2 in the same way (in
relation to the PUFA content of diet and milk) yielded a
factor of 0·96. Since Bee(4) documented in his publication a
discrimination factor of only 0·69, this suggests that some of
the cis-9,trans-11-18 : 2 in the present study derives from VA.
Compared with the MA dietary treatment, the total CLA
content in sow milk was significantly increased during the
BU dietary treatment. This is in agreement with findings
from human studies, in which a CLA-rich diet led to an
increased CLA concentration in mothers’ milk(6,9,15,27). The
basal CLA concentration in the mothers’ milk determined in
the study of Bertschi et al. (15) was higher than that observed
in the mature milk of the sows, which is probably the result
of the normally higher CLA intake by humans than by
sows. The lactation diet of sows does not usually contain
any natural sources of CLA. However, after supplying the
diet with alpine butter the increase in the overall CLA concen-
tration was higher in the milk of sows (560 and 883 % of basal
values for group A and B, respectively) than in the milk of the
mothers (128 and 169 % for the two groups, respectively) in
the study of Bertschi et al. (15), so that total CLA concentration
in milk fat after the BU diet was twice as high in sows (683·3
and 808·7 mg/100 g fat in group A and B, respectively) com-
pared with humans (397·9 and 436·6 mg/100 g fat(15)). These
findings were expected because in the sow diet the sole dietary
fat source was alpine butter whereas in the human study the
alpine butter was one part of the total dietary fat. Considering
that sow milk contains about twice as much milk fat than
human milk (during alpine butter dietary treatment: 7·3 g/
100 ml in sow milk and 3·4 g/100 ml in human milk), this
results in a four times higher amount of CLA per ml milk in
sows than in human mothers. This seems to be in agreement
with the fact that the sows ingested with the BU diet daily
about four times the amount of CLA than the women (20·8
v. 5·9 mg/kg body weight). The results suggest that there is
potential to substantially increase the CLA content of human
milk; however, it is still unclear to what extent. Fogerty
et al. (28) reported a high CLA concentration in the milk of
Hare Krishna mothers (1120 mg/100 g fat) and attributed it
to a high consumption of butter, ghee and cheese. However,
Precht & Molkentin(29) have analysed milk samples of forty
German women and the result (400 (SD 90) mg CLA/100 g
fat) documents that usually CLA concentration in human
milk is lower.
In previous studies, only a few CLA isomers were deter-
mined in human(6,9) and sow milk(4). Most analyses concentrate
on the predominant cis-9,trans-11-18 : 2. Bertschi et al. (15)
were the first to describe the levels of fourteen individual
CLA isomers in human milk. In the present study, the behaviour
of most individual CLA isomers was homogeneous insofar
as concentrations increased in the sow milk during the BU diet-
ary treatment. Exceptions were, as already mentioned, trans-
10,trans-12-, trans-10,cis-12- and trans-8,trans-10-18 : 2,
which is ascribable to the fact that the concentrations of these
isomers were similar or even higher in the MA compared
with the BU diet. Calculating the discrimination factors, in
relation to total PUFA concentration as described above,
may provide an indication of the transfer efficiency of the
individual isomers. This was done for all measured CLA iso-
mers with a concentration .10 mg/100 g fat in the BU feed.
The discrimination factors were similarly low for trans-
12,trans-14- (0·22), trans-11,trans13- (0·21) and trans-11,
cis-13-18 : 2 (0·26). By contrast, cis-9,trans-11- (0·96), trans-
7,cis-9- (1·03), and trans-8,cis-10-18 : 2 (1·57) were incorpor-
ated at a very high level, whereas trans-9,trans-11-8 : 2 (0·47)
ranged in the middle. This suggests that individual CLA
isomers are not absorbed proportionally from the diet but
may also indicate differences in metabolism or variations in
tissue deposition of individual CLA isomers. Since the total
volume of sow milk could not be collected, a definitive con-
clusion regarding the quantitative transfer of individual CLA
isomers and fatty acids cannot be drawn.
Milk fat usually contains trans-11,cis-13-18 : 2 and trans-
7,cis-9-18 : 2 in a ratio of about 0·3. Alpine milk diverges
from this with a ratio of about 3·0 which can be used to con-
firm the alpine origin(21). This is above all due to an increased
trans-11,cis-13-18 : 2 concentration of highland compared
with lowland milk. The trans-11,cis-13 to trans-7,cis-9-18 : 2
ratio in the BU diet was 3·4. However, in the milk fat of the
sows this ratio was only 0·9 during BU feeding. Similarly,
Bertschi et al. (15) reported a trans-11,cis-13 to trans-7,cis-9-
18 : 2 ratio of 1·1 in human milk fat during alpine butter sup-
plementation. The above-documented discrimination factors
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Fig. 1. Mean body weight (kg) of litter (n 135) during the study period for all
animals (-S-), group A (- -) and group B (-O-). Values are means.
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indicate that the ratio change is basically due to a limited
transfer of trans-11,cis-13-18 : 2 from diet to milk whereas
trans-7,cis-9-18 : 2 goes over approximately 1 : 1. These find-
ings suggest that although trans-11,cis-13-18 : 2 is increased
by highland pasturing of cows, the higher concentration is
not utilised by the organisms of sows and humans.
The growth performance of the piglets was not influenced by
dietary treatments, which may be due to the short (10 d) inter-
vention period. Since the main objective of the present study
was to investigate the impact of a diet with alpine butter on
the fatty acid composition of sow milk, the study was not
specifically designed to determine the effect of CLA supply
on the growth performance of the progeny. Further studies
with longer intervention periods will have to look more specifi-
cally into this matter. However, results from Bee(5) suggest that
a CLA supplementation of sows during lactation is not suffi-
cient but has to be continued in the post-weaning period to
significantly enhance the weight of piglets.
In summary, the findings show that CLA originating from
alpine butter positively affects the CLA content of sow milk
without provoking a milk fat depression and altering the compo-
sition of total SFA, MUFA and PUFA. Furthermore, the data
suggest that individual CLA isomers do not go over proportion-
ally from the diet into the milk. However, further studies are
necessary to evaluate the quantitative transfer of individual
CLA isomers and their physiological effects in the progeny.
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